Role of TAZ in Lysophosphatidic Acid-Induced Migration and Proliferation of Human Adipose-Derived Mesenchymal Stem Cells |
Mo, Won Min
(Department of Physiology, Pusan National University School of Medicine)
Kwon, Yang Woo (Department of Physiology, Pusan National University School of Medicine) Jang, Il Ho (Department of Oral Biochemistry and Molecular Biology, Pusan National University School of Dentistry) Choi, Eun Jung (Department of Physiology, Pusan National University School of Medicine) Kwon, Sang Mo (Department of Physiology, Pusan National University School of Medicine) Kim, Jae Ho (Department of Physiology, Pusan National University School of Medicine) |
1 | Pebay, A., Bonder, C. S. and Pitson, S. M. (2007) Stem cell regulation by lysophospholipids. Prostaglandins Other Lipid Mediat. 84, 83-97. DOI |
2 | Ramos, A. and Camargo, F. D. (2012) The Hippo signaling pathway and stem cell biology. Trends Cell Biol. 22, 339-346. DOI |
3 | Tang, N., Zhao, Y., Feng, R., Liu, Y., Wang, S., Wei, W., Ding, Q., An, M. S., Wen, J. and Li, L. (2014) Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. J. Cell. Mol. Med. 18, 156-169. DOI |
4 | van Meeteren, L. A. and Moolenaar, W. H. (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 46, 145-160. DOI |
5 | Varelas, X. (2014) The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141, 1614-1626. DOI |
6 | Chen, J., Baydoun, A. R., Xu, R., Deng, L., Liu, X., Zhu, W., Shi, L., Cong, X., Hu, S. and Chen, X. (2008) Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells 26, 135-145. DOI |
7 | Chen, X., Yang, X. Y., Wang, N. D., Ding, C., Yang, Y. J., You, Z. J., Su, Q. and Chen, J. H. (2003) Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction. Scand. J. Clin. Lab. Invest. 63, 497-503. DOI |
8 | Cordenonsi, M., Zanconato, F., Azzolin, L., Forcato, M., Rosato, A., Frasson, C., Inui, M., Montagner, M., Parenti, A. R., Poletti, A., Daidone, M. G., Dupont, S., Basso, G., Bicciato, S. and Piccolo, S. (2011) The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759-772. DOI |
9 | Frankel, A. and Mills, G. B. (1996) Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. Clin. Cancer Res. 2, 1307-1313. |
10 | Cselenyak, A., Pankotai, E., Horvath, E. M., Kiss, L. and Lacza, Z. (2010) Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol. 11, 29. DOI |
11 | Hong, W. and Guan, K. L. (2012) The YAP and TAZ transcription coactivators: key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 23, 785-793. DOI |
12 | Geng, Y. J. (2003) Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann. N. Y. Acad. Sci. 1010, 687-697. DOI |
13 | Halder, G. and Johnson, R. L. (2011) Hippo signaling: growth control and beyond. Development 138, 9-22. DOI |
14 | Hao, Y., Chun, A., Cheung, K., Rashidi, B. and Yang, X. (2008) Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496-5509. DOI |
15 | Hu, X., Haney, N., Kropp, D., Kabore, A. F., Johnston, J. B. and Gibson, S. B. (2005) Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB. J. Biol. Chem. 280, 9498-9508. DOI |
16 | Iyer, S. S. and Rojas, M. (2008) Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin. Biol. Ther. 8, 569-581. DOI |
17 | Johnson, R. and Halder, G. (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63-79. DOI |
18 | Li, Z., Wei, H., Liu, X., Hu, S., Cong, X. and Chen, X. (2010b) LPA rescues ER stress-associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells. J. Cell. Biochem. 111, 811-820. DOI |
19 | Lindroos, B., Suuronen, R. and Miettinen, S. (2011) The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. 7, 269-291. DOI |
20 | Li, N., Sarojini, H., An, J. and Wang, E. (2010a) Prosaposin in the secretome of marrow stroma-derived neural progenitor cells protects neural cells from apoptotic death. J. Neurochem. 112, 1527-1538. DOI |
21 | Aggarwal, S. and Pittenger, M. F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822. DOI |
22 | Anliker, B. and Chun, J. (2004) Cell surface receptors in lysophospholipid signaling. Semin. Cell Dev. Biol. 15, 457-465. DOI |
23 | Badri, L. and Lama, V. N. (2012) Lysophosphatidic acid induces migration of human lung-resident mesenchymal stem cells through the -catenin pathway. Stem Cells 30, 2010-2019. DOI |
24 | Binder, B. Y., Genetos, D. C. and Leach, J. K. (2014) Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis. Tissue Eng. Part A 20, 1156-1164. DOI |
25 | Chan, S. W., Lim, C. J., Guo, K., Ng, C. P., Lee, I., Hunziker, W., Zeng, Q. and Hong, W. (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68, 2592-2598. DOI |
26 | Willier, S., Butt, E. and Grunewald, T. G. (2013) Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Biol. Cell 105, 317-333. DOI |
27 | Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S. and Dzau, V. J. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201. DOI |
28 | Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X. D., Mills, G. B. and Guan, K. L. (2012) Regulation of the Hippo-YAP pathway by Gprotein-coupled receptor signaling. Cell 150, 780-791. DOI |
29 | Liu, C. Y., Zha, Z. Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., Li, T., Chan, S. W., Lim, C. J., Hong, W., Zhao, S., Xiong, Y., Lei, Q. Y. and Guan, K. L. (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169. DOI |
30 | Liu, X., Hou, J., Shi, L., Chen, J., Sang, J., Hu, S., Cong, X. and Chen, X. (2009) Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem Cells Dev. 18, 947-954. DOI |
31 | Murphy, M. B., Moncivais, K. and Caplan, A. I. (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 45, e54. DOI |
32 | Ohta, H., Sato, K., Murata, N., Damirin, A., Malchinkhuu, E., Kon, J., Kimura, T., Tobo, M., Yamazaki, Y., Watanabe, T., Yagi, M., Sato, M., Suzuki, R., Murooka, H., Sakai, T., Nishitoba, T., Im, D. S., Nochi, H., Tamoto, K., Tomura, H. and Okajima, F. (2003) Ki16425, a subtype-selective antagonist for EDG-Family lysophosphatidic acid receptors. Mol. Pharmacol. 64, 994-1005. DOI |
33 | Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C. X., Brugge, J. S. and Haber, D. A. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U.S.A. 103, 12405-12410. DOI |
34 | Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A. and Anversa, P. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U.S.A. 98, 10344-10349. DOI |